Feb 5 (Reuters) - Drug distributor Cencora (COR.N), opens new tab raised its fiscal 2025 profit forecast on Wednesday, driven by robust demand for expensive specialty medicines. The Conshohocken ...

Walgreens Boots Alliance has sold more shares of drug distributor Cencora for proceeds of about $300 million, “primarily for debt paydown and general corporate purposes,” the company said ...

Ahead of the event, analysts expect Cencora to report a profit of $3.50 per share, up 6.7% from $3.28 in the year-ago quarter.The company has consistently surpassed Wall Street’s adjusted EPS ...

Shares of Cencora (COR) have been strong performers lately, with the stock up 13.4% over the past month. The stock hit a new 52-week high of $256.81 in the previous session. Cencora has gained 13. ...

Cencora (COR) has significantly expanded the number and type of medications available in its sure supply program, a drug shortage mitigation initiative designed to provide health systems with ...

Hello and welcome everyone to the Cencora Q1 fiscal year 2025 earnings call. My name is Becky and I’ll be your Operator today. During the presentation, you can register a question by pressing ...